Medulloblastoma (MB) represents the most common childhood malignant brain tumor. Even though 60-70% of children with non-metastasized MB have a five-year survival rate after aggressive multimodal therapy, including surgery, radiotherapy, and chemotherapy, a significant proportion of surviving patients suffer from severe treatment-related side effects, especially from leukoencephalopathy and cognitive deficits, and often have tumor relapse. This presents an urgent need for novel therapeutic modalities that can improve MB patient survival while minimizing adverse side effects. Activation of either the Sonic Hedgehog (SHH) pathway or the WNT signaling pathway is found in about 40% of human MBs, critical for the initiation and growth of MB, and a prime therapeutic target for treating patients with MBs. Although the outlook for MB therapy with Shh inhibitors is promising, drug resistance and side effects can occur, thus presenting a roadblock to the prospect of Shh pathway inhibitors in advancing MB therapy. Identifying and targeting key pathways that are vital to MB growth is essential to overcoming this challenge. While investigating the role of the G-protein coupled receptor signaling pathway in brain development, strikingly, we found that mice with GS alpha alleles ablated in neural stem/progenitor cells developed MB with 100% penetrance. Our preliminary studies indicate that mice with GS alpha deletion developed two major subtypes of MBs, SHH- and WNT- subtypes, depending on the cellular context. Transplantation of freshly isolated tumor cells from GS alpha mutants produced MB-like tumors in xenograft mice. Collectively, we have established a novel animal model of MB, where GS alpha ablation in anatomically distinct neural precursor cells gives rise to different subtypes of MBs. We hypothesize that GS alpha signaling orchestrates Shh and Wnt signaling pathways in MB formation, and may serve as a potential therapeutic target for MB treatment. We will first determine the progenitor cell types that are competent to form MBs induced by GS alpha mutation. Second, we will identify define the critical downstream pathways that drive tumorigenesis in GS alpha mutants. Third, we will test the hypothesis that MB formation induced by GS alpha deletion requires activation of Shh and Wnt signaling pathways by genetic and pharmacological approaches. Thus, these proposed studies will advance our understanding of the pathogenesis and treatment of MB at molecular and cellular levels should facilitate devising new, effective strategies to treat these deadly pediatric brain cancers.

Public Health Relevance

The work proposed in research plans will provide better understanding of cancer pathways and critical signals that drive tumorigenesis in medulloblastoma. It will not only have scientific merits but also could be of practical value in treating patients with the devastating malignant brain tumor of childhood.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS078092-01
Application #
8274550
Study Section
Molecular Oncogenesis Study Section (MONC)
Program Officer
Fountain, Jane W
Project Start
2012-04-01
Project End
2017-03-31
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
1
Fiscal Year
2012
Total Cost
$347,356
Indirect Cost
$128,606
Name
University of Texas Sw Medical Center Dallas
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Gregath, Alexander; Lu, Qing Richard (2018) Epigenetic modifications-insight into oligodendrocyte lineage progression, regeneration, and disease. FEBS Lett 592:1063-1078
Koreman, Elijah; Sun, Xiaowei; Lu, Q Richard (2018) Chromatin remodeling and epigenetic regulation of oligodendrocyte myelination and myelin repair. Mol Cell Neurosci 87:18-26
Zhao, Chuntao; Dong, Chen; Frah, Magali et al. (2018) Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair. Dev Cell 45:753-768.e8
Jiang, Minqing; Rao, Rohit; Wang, Jincheng et al. (2018) The TSC1-mTOR-PLK axis regulates the homeostatic switch from Schwann cell proliferation to myelination in a stage-specific manner. Glia 66:1947-1959
Wu, Lai Man Natalie; Deng, Yaqi; Wang, Jincheng et al. (2018) Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. Cancer Cell 33:292-308.e7
Laitman, Benjamin M; Asp, Linnéa; Mariani, John N et al. (2016) The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination. PLoS Biol 14:e1002467
Lu, Fanghui; Chen, Ying; Zhao, Chuntao et al. (2016) Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma. Cancer Cell 29:669-683
Ju, Jun; Liu, Qian; Zhang, Yang et al. (2016) Olig2 regulates Purkinje cell generation in the early developing mouse cerebellum. Sci Rep 6:30711
Wu, Lai Man Natalie; Wang, Jincheng; Conidi, Andrea et al. (2016) Zeb2 recruits HDAC-NuRD to inhibit Notch and controls Schwann cell differentiation and remyelination. Nat Neurosci 19:1060-72
He, Danyang; Marie, Corentine; Zhao, Chuntao et al. (2016) Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination. Nat Neurosci 19:678-689

Showing the most recent 10 out of 29 publications